AlphaGrep UK’s Colgate-Palmolive CL Stock Holding History

AlphaGrep UK’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,845	Closed	-$583K	–	770
2026 Q1	$583K	Sell	6,845 -2,370	-26%	-$211K	0.17%	172
2025 Q4	$728K	Buy	+9,215	New	+$722K	0.24%	90

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

AlphaGrep UK's CL Position: Q2 2026 in Review

AlphaGrep UK sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 6,845 shares — an estimated $583K sold.

AlphaGrep UK first reported a position in CL in Q4 2025 and held it in 2 quarters. The position peaked at $728K in Q4 2025. 1,923 funds tracked by Wall St. Rank hold CL as of Q2 2026.

AlphaGrep UK reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 6,845 Colgate-Palmolive shares in Q2 2026, an estimated $583K.
AlphaGrep UK first reported a position in Colgate-Palmolive in Q4 2025 and held it in 2 quarters.
AlphaGrep UK's Colgate-Palmolive position peaked at $728K in Q4 2025.
1,923 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.